Human peripheral blood mononuclear cell proliferation induced by Mycobacterium leprae could be inhibited by the suppressor factor in the lysate of the macrophages of lepromatous leprosy patients. Macrophages from normal subjects and tuberculoid patients did not show production of a suppressor factor. Inhibition occurred only when the factor was present in the initial stages of lymphocyte culture. The factor is heat stable and nondialyzable. Proliferation induced by some mycobacteria and concanavalin A could also be blocked by the factor. Interestingly, blastogenic response by a few other antigens and phytohemagglutinin could not be inhibited by the suppressor factor. Mononuclear cells pretreated with such lysate from lepromatous macrophages for 24 h could induce suppressive activity in the cells in vitro in an autologous system. Treatment of these cells with carbonyl iron after the induction phase, to remove phagocytic cells, did not abolish their suppressive activity. The lepromatous macrophage lysate also generated suppressive activity in a T-lymphocyte-enriched population of normal subjects. These studies are interpreted to indicate that immunosuppression in lepromatous patients is produced by both macrophages and T lymphocytes. The exact phase in which either of these cells acts as a suppressor may be different. Specific suppression by macrophages to M. leprae can be an early event, and nonspecific suppression by T lymphocytes may be a later event in the course of lepromatous leprosy.
Human leprosy exhibits a wide spectrum, ranging from the tuberculoid type with high immunity to the lepromatous type showing depressed cell-mediated immunity. Attempts to delineate the mechanisms of anergy in lepromatous leprosy have resulted in confficting data. Early workers indicated a defective lymphocyte population as being responsible for the low immune response to Mycobacterium leprae in lepromatous leprosy (8, 17) . Hirschberg (11) identified the lepromatous macrophage as being the defective cell in leprosy. This was confirmed in another study with HLA-matched individuals (20) . Our earlier studies (24) have also indicated that an impairment in macrophage metabolism could be responsible for lowered cell-mediated immunity in lepromatous leprosy.
There is now growing evidence for the importance of suppressor cell-mediated immunoregulation in mycobacterial infections (6, 14, 28 Wadee et al. (26) .
In the present study we have investigated the possibility of a macrophage-derived inhibitory product negatively modulating lymphocyte proliferation. The study of this product could make it possible to examine the mechanism of immunosuppression in an in vitro system. (24) . After Separation of T lymphocytes and suppressor cell induction. A T-lymphocyte-enriched population was obtained from normal subjects by the nylon wool column technique (9) . The T-lymphocyte-enriched population was exposed for 24 h to LL lysate and was checked for inhibitory activity to ConA stimulation as described above.
RESULTS
Effect of macrophage lysate on normal lymphocyte proliferation. When LL lysate was added to normal mononuclear cell cultures activated with M. leprae, substantial suppression of blastogenesis was observed. When TT lysate or N lysate was added to the normal culture, no inhibition was observed (Fig. 1) (Fig. 3) . Normal lymphocyte blastogenesis to PHA was also not affected by LL lysate (Table 2 ). In the five experiments with ICRC, stimulation was inhibited by the LL lysate in only one case (Fig. 3) .
Ability of LL lysate to activate suppressor cells in vitro. LL lysate was added to a normal mononuclear cell culture to induce suppressor activity. It was capable of inducing a suppressor cell population when tested in coculture experiments (Fig. 4 and 5) . The level of suppression was 67 ± 11% for the ConA response and 86 + 7% for the M. leprae response ( Table 3 ). The suppressor cells were nonspecific in their action as they inhibited both ConA-and M. Iepraemediated stimulation (Fig. 4 and 5) . Mononuclear cells of tuberculoid patients also showed significant suppression in the presence of autologous cells treated with LL lysate (Fig. 4 and 5 (Table 5) .
Effect of LL lysate on T-lymphocyte-enriched cells. LL lysate was capable of inducing suppressive activity in the T-lymphocyte-enriched cell population (Table 6) .
DISCUSSION
These experiments demonstrate that lepromatous macrophages produce immunosuppressive factors which could be responsible for the lowered cell-mediated immune response observed in lepromatous patients. We have preliminary data to show that a sonicate of M. leprae antigen had stimulatory capacity similar to that of whole M. leprae. The ability of M. leprae lysates to inhibit whole M. Ieprae-induced proliferation may give information to determine whether the factor is bacterial or derived from the host cell. However, the results presented in Table 1 and Fig. 1 for normal and tuberculoid macrophage lysates and cycloheximide-treated lepromatous macrophage lysates also give certain indications whether the lysate is a host cell or a bacterial product. Lysates prepared from normal and tuberculoid macrophages exposed to M. leprae in vitro did not show any inhibitory activity. These results support the conclusion that the suppressor factor is not a direct product of M. leprae. Lysate made from cycloheximide-treated macrophages and macrophages exposed to heat-killed M. leprae also do not show any inhibitory activity. This also favors the possibility that the observed effects are not due to bacillary products but most likely are macrophage products. C-LL(-ve) lysate showed no inhibitory action, but the addition of M. leprae to the macrophage cultures induced the production of the suppressor factor. These findings suggest that an active interaction between the lepromatous macrophages and the bacilli is required for the induction of the suppressor factor. The inhibitor is heat stable and nondialyzable. In vitro production of this factor was not affected by concomitant incubation with indomethacin, a prostaglandin synthetase inhibitor, suggesting that the factor is not a prostaglandin (data not shown).
Among the monocyte factors that have suppressor activity are the dialyzable and the heatstable factors (5, 27) . Furthermore, arginase and unlabeled thymidine (21) (3, 19) . This correlates with our observation that mitogenic and antigenic stimulation of Several studies have emphasized a crucial role for macrophages in regulating T-cell-dependent reactivities (10, 23) . First, macrophages may be required to present antigens or mitogens to T cell recognition units in a manner required for T cell activation. Second, macrophages may modulate T cell reactivity through the liberation of soluble immunoregulatory molecules. These sol- uble products may exert a direct effect on responding T cells. Alternatively, as the data presented here suggest, some immunoregulatory material liberated by macrophages may indirectly affect responding T cell subsets. The studies presented here indicate that the macrophage or its products and T cell interaction is required to generate suppression. Although this circular interaction between macrophages and T cells may seem unduly complicated, it is consistent with the known complexities of cell interaction originally proposed by Jerne (13) .
Cells treated with carbonyl iron after the induction phase still showed suppressive activity to ConA stimulation. These results suggest that the suppressor cell induced in vitro is a lymphocyte. T lymphocyte enrichment methods show that the suppressor lymphocyte is a T cell. However, further enrichment methods for T lymphocytes and T suppressor lymphocytes are in progress. The action of the suppressor cells generated in vitro was nonspecific in its action as it inhibited both ConA and M. leprae stimulation.
In other experiments, we have shown that the lysate also inhibits certain macrophage functions (manuscript in preparation). Taking all the above data into consideration, we hypothesize that in vitro, macrophages of the susceptible individual infected with M. leprae produce immunosuppressors which act nonspecifically and systemically by altering macrophages and T lymphocytes. Huchet and Florentine (12) have suggested that a low dose of M. bovis BCG would mainly favor the induction of suppressor macrophages, whereas larger doses could lead to the induction of T cells in addition. Mehra et al. (18) have also reported that M. Ieprae-induced suppression in vitro was produced by an adherent cell and an E rosetting cell. Over and above the T-suppressor cells induced by lepromin, the presence of these cells in lepromatous patients in the above study could be due to in vivo activation of T cells by certain products released from the monocyte. The authors do show the presence of adherent suppressor cells in vitro also.
These experiments are important in our understanding of the abnormal immune responses in mycobacterial diseases. They could indicate a central role for both macrophages and T cells. Adherent cells of patients with disseminated fungal infection released a soluble factor that was capable of inhibiting the blastogenic response of normal T cells, probably by generating T-suppressor cells (25) . Further, in experimental malaria and Trypanosoma brucei infection, both macrophages and T cells have been shown to be affected by the parasites, resulting in immunodepression (7, 16).
In leprosy, which presents a complex disease spectrum, there may well be more than one immunological mechanism operative in regulation of the immune response to leprosy bacilli.
